Acid proteinase enzyme activity in Candida albicans strains: a comparison of spectrophotometry and plate methods

In recent years, the incidence of fungal infections has been rising all over the world. Although the amount of research in the field of pathogenic fungi has also increased, there is still a need for studies on fungal virulence. In this investigation, we focused on testing bloodstream-identified Candida albicans in experimental in vitro virulence assays. The proteinase enzyme activities of 30 C. albicans strains isolated from the bloodstream and sterile body fluids were investigated (15 colonizations, 15 infections). The spectrophotometric and plate methods were used to determine proteinase activity. The correlations between the 2 methods were compared. This study indicates that, in terms of proteinase activity, there were no statistically significant differences between strains obtained from infection and colonization sites by either method (P > 0.05).

Anahtar Kelimeler:

Key words: Candida albicans, secreted aspartyl proteinase (SAP) activity, virulence

Acid proteinase enzyme activity in Candida albicans strains: a comparison of spectrophotometry and plate methods

Keywords:

Key words: Candida albicans, secreted aspartyl proteinase (SAP) activity, virulence,

PDF

___

Navarro-Garcia F, Sánchez M, Nombela C et al. Virulence genes in the pathogenic yeast C. albicans. FEMS Microbiology Reviews 25: 225-268, 2001.
Gokce G, Cerikcioglu N, Yagci A. Acid proteinase, phospholipase and biofi lm production of Candida species isolated from blood cultures. Mycopathologia 164: 265-269, 2007.
Zaugg C, Borg-von Zepelin M, Reichard U et al. Secreted aspartic proteinase family of Candida tropicalis. Infect Immun 69: 405-412, 2001. 4. Pfaller MA. Epidemiology and control of fungal infections. Clin Infect Dis 19: 8-13, 1994.
Edmond MB, Wallace SE, McClish DK et al. Nosocomial bloodstream infections in United States hospitals: a three year analysis. Clin Infect Dis 29: 239-244, 1999.
Wey SB, Mori M, Pfaller MA et al. Hospital acquired candidemia. Th e attributable mortality and excess length of stay. Arch Intern Med 148: 2642-2645, 1998. 7. Yun-Liang Y. Virulence factors of Candida species. J Microbiol Immunol Infect 36: 223-228, 2003.
Kremery V, Barnes AJ. Non-albicans Candida spp. causing fungemia: pathogenicity and antifungal resistance. J Hosp Infect 50: 243-60, 2002. 9. Soll DR. High frequency switching in Candida albicans. Clin Microbiol Rev 5: 183-203, 1992.
Ofek I, Beachey EH. General concepts and principles of bacterial adherence in animal and man. In: Beachey EH. ed. Bacterial Adherence. Chapman and Hall; 1980: pp 1-15.
Douglas LJ. Adhesion of pathogenic Candida species to host surfaces. Microbiol Sci 2: 243-247, 1982.
Hube B, Naglik JR. Extracellular hydrolases. In: Calderone RA. ed. Candida and Candidiasis. American Society for Microbiology Press; 2002: pp 107-122.
Staib F. Proteolysis and pathogenicity of C. albicans strains. Mycopathologia 37: 345-348, 1969.
Molbay D, Ulgen N, Ener B et al. Proteinase activity of Candida species isolated from various clinical specimens. 7th International Congress of Mycology Division, Prague, Czech Republic, 1994.
Borg M, Rüchel R. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect Immun 56: 626-631, 1988.
Schaller M, Bein M, Korting HC et al. Th e secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun 71: 3227-3234, 2007.
Tümbay E. Candida türleri. In Ustaçelebi Ş. ed. Temel ve Klinik Mikrobiyoloji. Günes Kitabevi; 1999: pp. 1081-1086.
Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 3: 685-702, 2003.
Lunel FMV, Meis JFGM, Voss A. Nosocomial fungal infections: Candidemia. Diagn Microbiol Infect Dis 34: 213-220, 1999.
Chakrabarti A, Nayak N, Talwar P. In vitro proteinase production by Candida species. Mycopathologia 114: 163-168, 1991.
Rüchel R, Baring B, Borg M. Characterization of a secretory proteinase of Candida parapsilosis and evidence for the absence of the enzyme during infection in vitro. Infect Immun 53: 411- 419, 1986.
Cassone A, De Bernardis F, Mondello F et al. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis 156: 73-83, 1987.
Rüchel R, Tegeler R, Trost MA. Comparison of secretory proteinases from diff erent strains of Candida albicans. Sabouraudia 20: 233-244, 1982.
Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 20: 7-14, 1982.
Girish Kumar CP, Jothi Kumar SS, Menon T. Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients. Mycopathologia 161: 213-218, 2006.
De Bernardis F, Mondello F, Millan SR et al. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J Clin Microbiol 37: 3481-3486, 1999.
Lyon JP, de Resende MA, Gerais M. Correlation between adhesion, enzyme production and susceptibility to fl uconazole in Candida albicans obtained from denture wearers. Oral Med Oral Pathol Oral Radiol Endod 102: 632-638, 2006.
Tsoubi R, Matsuda K, Kol J et al. Correlation between active medium pH, extracellular proteinase activity and cell growth of Candida albicans in soluble stratum corneum-supplemented media. Arch. Dermatol 281: 342-345, 1989.
Stewens DA, Odds FC, Scherer S. Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype. Rev Infect Dis 12: 258-266, 1990.
Kan İ. Biyoistatistik. Uludağ Universitesi Ü Basimevi. Bursa; 1994: pp. 128-143.
De Bernardis FL, Agatensi IK, Ross GW et al. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J Infect Dis 161: 1276-1283, 1990.
De Bernardis F, Boccanera M, Adriani D et al. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun 65: 3399-3405, 1997.
MacDonald F, Odds FC. Virulence for mice of a proteinase secreting strain of Candida albicans and a proteinase defi cient mutant. J Gen Microbiol 29: 431-438, 1983.
Staib F. Serum proteins as nitrogen source for yeast-like fungi. Sabouraudia 4: 187-193, 1965.
De Bernardis F, Sullivan PA, Cassoni A. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med Mycol 39: 303-313, 2001.
Kantarcioğlu SA, Yücel A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses 45: 160-165, 2002.
Hube B. Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol 1: 55-69, 1996.
Hannula J, Saarela M, Dogan B et al. Comparison of virulence factors of oral Candida dubliniensis and Candida albicans isolates in healthy people and patients with chronic candidosis. Oral Microbiol Immunol 15: 238-244, 2000.
Al-Hedaithy SS. Spectrum and proteinase production of yeasts causing vaginitis in Saudi Arabian Women. Med Sci Monit 8: 498-501, 2002.
Oksuz S, Sahin I, Yildirim M et al. Phospholipase and proteinase activities in diff erent Candida species isolated from anatomically distinct sites of healthy adults. Jpn J Infect Dis 60: 280-283, 2007.
Matsumoto PE, Gandra RF, Ruiz LS et al. Yeast isolated from blood and catheter in children from a public hospital of São Paulo, Brazil. Mycopathologia 154: 63-9, 2001.
Kalkancı A, Kuştimur S, Bozdayı G et al. Virulence factors and susceptibility pattern of Candida strains isolated from patients with vulvovaginal candidiasis. T Mikrobiol Cem Derg 33: 323- 328, 2003.
Ozkan S, Kaynak F, Kalkanci A et al. Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents. Mem Inst Oswaldo Cruz Rio de Janeiro 100: 319-324, 2005.
Fotedor R, Al-Hedaithy SSA. Comparison of phospholipase and proteinase activity of Candida albicans and C. dubliniensis. Mycoses 48: 62-67, 2005.
Kothavade RJ, Panthaki MH. Evaluation of phospholipase activity of Candida albicans and its correlation with pathogenicity in mice. J Med Microbiol 47: 99-102, 1998.
Cerikçioğlu N, İlki A, Bilgen A et al. Th e relationship between candidemia and candidal colonization and virulence of colonizing strains in preterm infants. Turk J Pediatr 46: 245- 250, 2004.
Yücel A, Kantarcıoğlu AS. Th e determination of some virulence factors (phospholipase, protease, germ tube formation and adherence) of C. albicans and the correlative relationship of the factors. Turk J Infect 15: 517-525, 2001.
Pfaller MA, Jones RN, Doern GV et al. International surveillance of bloodstream infections due to Candida species; frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada and South America for the SENTRY program. J Clin Microbiol 36: 1886-1889, 1998.
Chaffi n WJ, Lopez-Ribot JL, Casanova M et al. Cell wall and secreted proteins of Candida albicans: identifi cation, function and expression. Microbiol Mol Biol Rev 62: 130-180, 1998.
De Bernardis F, Mondello F, Scaravelli G et al. High aspartyl proteinase production and vaginitis in human immunodefi ciency virus-infected women. J Clin Microbiol 37: 1376-1380, 1999.
Ozcan SK, Budak F, Yucesoy G et al. Prevalence, susceptibility profi le and proteinase production of yeasts causing vulvovaginitis in Turkish women. APMIS 114: 139-145, 2006.